Discontinued — last reported Q2 '24
STERIS Accrued sales commissions increased by 1.2% to $33.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $34.71M to $33.80M. Over 4 years (FY 2021 to FY 2025), Accrued sales commissions shows an upward trend with a 4.1% CAGR.
other_accrued_sales_commission_current_and_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.85M | $33.30M | $37.04M | $31.70M | $34.45M | $36.41M | $32.30M | $31.10M | $34.00M | $35.10M | $36.39M | $33.28M | $32.93M | $34.06M | $34.71M | $32.10M | $32.80M | $33.40M | $33.80M |
| QoQ Change | — | +4.5% | +11.2% | -14.4% | +8.7% | +5.7% | -11.3% | -3.7% | +9.3% | +3.2% | +3.7% | -8.5% | -1.0% | +3.4% | +1.9% | -7.5% | +2.2% | +1.8% | +1.2% |
| YoY Change | — | — | — | — | +8.2% | +9.3% | -12.8% | -1.9% | -1.3% | -3.6% | +12.7% | +7.0% | -3.1% | -2.9% | -4.6% | -3.5% | -0.4% | -1.9% | -2.6% |